Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;17(9):e2200154.
doi: 10.1002/biot.202200154. Epub 2022 Jun 9.

A study of the THP-1 cell line as the potential biologics production platform with the emphasis on serum-free media substitution for economic expediency

Affiliations

A study of the THP-1 cell line as the potential biologics production platform with the emphasis on serum-free media substitution for economic expediency

Ilgin Kimiz-Gebologlu et al. Biotechnol J. 2022 Sep.

Abstract

Cell cultures are frequently preferred in the industrial production of high value-added biopharmaceuticals on a large scale. In the production of biopharmaceuticals, the selection of the appropriate cell line, the cell culture medium, and the culture conditions are very important. In medical products to be offered for human use, authorized institutions do not allow the use of serum which increases the culture yield, added to the culture. For this reason, the cell lines to be used must be adapted to the serum-free medium. In this study, first, the direct and gradual adaptation of the THP-1 cell line, which has a high potential for use in biopharmaceutical production, to a locally produced chemically defined serum-free medium was carried out. Then, a comparison of the production efficiency in the shake flasks with the commercially available two different serum-free media was performed. Finally, for the first time, THP-1 cells were produced in spinner flasks and stirring tank bioreactor to simulate the large scale within the scope of this work.

Keywords: THP-1 cell line; bioprocess engineering; bioreactor production; mammalian cells; serum-free adaptation.

PubMed Disclaimer

References

REFERENCES

    1. Kumar, S., Sarma, P., Kaur, H., Prajapat, M., Bhattacharyya, A., Avti, P., Sehkhar, N., Kaur, H., Bansal, S., Mahendiratta, S., Mahalmani, V. M., Singh, H., Prakash, A., Kuhad, A., & Medhi, B. (2021). Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: A systematic review. Tissue and Cell, 70, 101497. https://doi.org/10.1016/j.tice.2021.101497
    1. Lokko, Y., Heijde, M., Schebesta, K., Scholtès, P., Van Montagu, M., & Giacca, M. (2018). Biotechnology and the bioeconomy-Towards inclusive and sustainable industrial development. New Biotechnology, 40, 5-10. https://doi.org/10.1016/j.nbt.2017.06.005
    1. Jagschies, G., Lindskog, E., Łacki, K., & Galliher, P. (2018). Biopharmaceutical processing: Development, design, and implementation of manufacturing processes. Elsevier. https://doi.org/10.1016/C2014-0-01092-1
    1. Kuystermans, D., & Al-Rubeai, M. (2015). Biopharmaceutical products from animal cell culture. In: Al-Rubeai, M. (Ed.), Animal Cell Culture. Cell Engineering. Springer, Cham, pp. 717-757. https://doi.org/10.1007/978-3-319-10320-4_23
    1. Gupta, V., Sengupta, M., Prakash, J., & Tripathy, B. C. (2016). In Basic and applied aspects of biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-10-0875-7

Substances

LinkOut - more resources